种系CDH1突变个体内镜检出遗传性弥漫性胃癌的相关因素
这项回顾性队列纳入98例种系致病性CDH1突变个体,评估内镜检出印戒细胞癌(SRCC)的相关因素。SRCC在内镜中检出20例(20%),在58例接受胃切除术者中检出50例(86%)。活检胃苍白黏膜区域及增加活检样本总数与SRCC检出相关(分别P < .01和P = .01),取≥40块样本时检出率为43%。
要点
- 胃苍白黏膜区域靶向活检与SRCC检出相关(P < .01)。
- 内镜活检样本总数增加与SRCC检出相关(P = .01),取≥40块时检出率43%。
- SRCC病灶多位于近端胃,支持更新的内镜监测指南。
核心结论
- 靶向活检胃苍白黏膜区域及增加内镜活检样本数均与SRCC检出相关,SRCC病灶多位于近端胃。
- 作者认为需进一步研究以优化内镜方案,改善该高危人群的SRCC检出。
研究设计与样本
- 回顾性队列纳入2006年1月1日至2022年3月25日在纪念斯隆凯特琳癌症中心接受至少1次内镜检查的98例种系致病性/可能致病性CDH1突变个体。
- 研究涵盖Cambridge内镜监测方案实施前后两个时期,以评估不同活检实践。
- 主要结局为内镜检出SRCC,同时评估胃切除术中的发现。
主要发现
- 内镜检出SRCC 20例(20%),58例接受胃切除术者中检出50例(86%)。
- SRCC病灶最常见于胃贲门/胃底(内镜50%,胃切除术62%)和胃体/移行带(内镜60%,胃切除术62%)。
- 活检胃苍白黏膜区域与SRCC检出相关(P < .01)。
- 内镜活检样本总数与SRCC检出增加相关(P = .01),取≥40块样本时检出率为43%。
关键数值与推荐
- 活检胃苍白黏膜区域与SRCC检出相关(P < .01)。
- 内镜活检样本总数与SRCC检出增加相关(P = .01),取≥40块样本时检出率为43%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Individuals with germline pathogenic CDH1 variants have a high risk of hereditary diffuse gastric cancer. The sensitivity of EGD in detecting signet ring cell carcinoma (SRCC) in this population is low. We aimed to identify endoscopic findings and biopsy practices associated with detection of SRCC. METHODS: This retrospective cohort included individuals with a germline pathogenic/likely pathogenic CDH1 variant undergoing at least 1 EGD at Memorial Sloan Kettering Cancer Center between January 1, 2006, and March 25, 2022. The primary outcome was detection of SRCC on EGD. Findings on gastrectomy were also assessed. The study included periods before and after implementation of the Cambridge protocol for endoscopic surveillance, allowing for assessment of a spectrum of biopsy practices. RESULTS: Ninety-eight CDH1 patients underwent at least 1 EGD at our institution. SRCC was detected in 20 (20%) individuals on EGD overall and in 50 (86%) of the 58 patients undergoing gastrectomy. Most SRCC foci were detected in the gastric cardia/fundus (EGD, 50%; gastrectomy, 62%) and body/transition zone (EGD, 60%; gastrectomy, 62%). Biopsy results of gastric pale mucosal areas were associated with detection of SRCC (P < .01). The total number of biopsy samples taken on EGD was associated with increased detection of SRCC (P = .01), with 43% detected when ≥40 samples were taken. CONCLUSIONS: Targeted biopsy sampling of gastric pale mucosal areas and increasing number of biopsy samples taken on EGD were associated with detection of SRCC. SRCC foci were mostly detected in the proximal stomach, supporting updated endoscopic surveillance guidelines. Further studies are needed to refine endoscopic protocols to improve SRCC detection in this high-risk population.
引用
- Laszkowska M, Tang L, Vos E, et al. Factors associated with detection of hereditary diffuse gastric cancer on endoscopy in individuals with germline CDH1 mutations. Gastrointest Endosc. 2023. PMID: 37094689. doi:10.1016/j.gie.2023.04.2071
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。